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Introduction
Secretory and endolysosomal organelles mature by the mem-
brane transport–dependent delivery of cargoes and removal of 
excess material. Cargo delivery requires sorting from a source 
compartment into nascent transport carriers; motility of the car-
riers toward the target organelle; and tethering, docking, and 
fusion of the carriers with the maturing target (Bonifacino and 
Glick, 2004). Cargo removal exploits similar processes and is 
particularly important to recycle fusion machinery components 
to the source membrane for additional rounds of cargo delivery 
(Bonifacino and Glick, 2004; Jahn and Scheller, 2006). Although 
the molecular details underlying fusion machinery cycling 
among early secretory pathway organelles are well developed 
(Cai et al., 2007; Barlowe and Miller, 2013), fusion machin-
ery trafficking in the endosomal system is poorly characterized. 
This cycling is particularly critical during the maturation of 
lysosome-related organelles (LROs), which comprise special-
ized cell type–specific organelles that derive from the endo-
somal system but support distinct physiological functions in 
metazoans (Marks et al., 2013). LRO biogenesis requires dedi-
cated and nonredundant pathways for content delivery; a similar 
dedicated pathway for content removal has not been described.
The importance of dedicated trafficking pathways in LRO 
biogenesis is underscored by Hermansky–Pudlak syndrome 
(HPS), a group of genetic diseases in which some LROs fail to 
mature properly with consequently impaired vision, skin and 
hair pigmentation, blood clotting, and often lung function (Wei, 
2006; Wei and Li, 2013). HPS results from mutations in any of 
at least 10 genes that encode subunits of four cytoplasmic mul-
tisubunit protein complexes: adaptor protein-3 (AP-3) and bio-
genesis of lysosome-related organelles complex (BLOC) 1, 2, 
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and 3 (Dell’Angelica, 2004; Di Pietro and Dell’Angelica, 2005). 
These complexes are thought to regulate membrane trafficking 
during LRO biogenesis, as best characterized in the maturation 
of melanosomes, the LROs in which melanins are synthesized 
and stored in pigment cells of the hair, skin, and eyes (Sitaram 
and Marks, 2012). AP-3, BLOC-1, and BLOC-2 affect the de-
livery of melanogenic enzymes, transporters, and accessory 
proteins from early endosomes to nonpigmented melanosome 
precursors via two pathways. One pathway requires BLOC-1 
(Setty et al., 2007, 2008; Cullinane et al., 2011; Sitaram et al., 
2012), together with the microtubule motor KIF13A and actin 
remodeling factors (Delevoye et al., 2009, 2016), for melano-
some cargoes to exit endosomes into tubular transport carriers. 
BLOC-2 then targets these carriers specifically to melano-
somes (Dennis et al., 2015). A second BLOC-1– and BLOC-2– 
independent pathway requires AP-3 for cargo sorting into mela-
nosome-bound vesicles (Huizing et al., 2001; Theos et al., 2005; 
Setty et al., 2007, 2008), although AP-3 can also cooperate with 
BLOC-1 (Newell-Litwa et al., 2009; Sitaram et al., 2012). How 
BLOC-3 functions during melanosome biogenesis is not clear. 
BLOC-3 is a guanine nucleotide exchange factor (GEF) for the 
cell type–restricted Rab GTPases RAB32 and RAB38 (Geron-
dopoulos et al., 2012). BLOC-3 and both Rabs are implicated 
in the biogenesis of melanosomes and other LROs (Wasmeier 
et al., 2006; Lopes et al., 2007; Osanai et al., 2010; Bultema et 
al., 2012, 2014), but whether they function in pathways into or 
out of melanosomes is not known.
To deliver their contents to maturing melanosomes, endo-
some-derived transport carriers must fuse with the melanosome 
membrane. Membrane fusion within the endomembrane system 
is mediated by SNA RE proteins (Chen and Scheller, 2001; Jahn 
and Scheller, 2006). Typically, engagement of v-SNA REs on 
transport carriers with cognate three-helix t-SNA RE complexes 
on target membranes leads to assembly of stable four-helix bun-
dles that destabilize the membrane and drive fusion (Domanska 
et al., 2010; Mohrmann et al., 2010). Several SNA REs have 
been implicated in melanosome biogenesis (Huang et al., 1999; 
Wade et al., 2001; Ghiani et al., 2010; Tamura et al., 2011; Yatsu 
et al., 2013; Jani et al., 2015), but among them, VAMP7 (also 
known as tetanus neurotoxin insensitive or TI-VAMP) is the 
only v-SNA RE. VAMP7 facilitates fusion of late endosomes 
with lysosomes (Luzio et al., 2010) and with maturing secretory 
autophagosomes (Fader et al., 2009, 2012), as well as glyco-
sylphosphatidylinositol-anchored protein delivery to the plasma 
membrane (Molino et al., 2015). An additional role for VAMP7 
in melanosome maturation is suggested by its localization to 
melanosomes (Jani et al., 2015) and by the hypopigmentation 
(Jani et al., 2015) and mistrafficking of the melanosomal protein 
TYRP1 (Tamura et al., 2011) in VAMP7-depleted cells. More-
over, the VAMP7- and RAB32/38-interacting protein VARP is 
required for proper TYRP1 localization (Tamura et al., 2009) 
and must bind VAMP7 for this function (Tamura et al., 2011). 
However, it is not known whether the VAMP7 requirement 
is direct or in which pathway it participates. Additionally, al-
though Hrb facilitates VAMP7 recycling from the plasma mem-
brane after fusion with VAMP7-containing organelles (Pryor et 
al., 2008), a pathway for recycling VAMP7 from intracellular 
organelles has not been described in any cell system.
Here, we exploit quantitative live-cell imaging analyses 
of VAMP7 dynamics in immortalized melanocytes from mouse 
HPS models. We show that VAMP7 is a BLOC-1–dependent 
cargo that likely functions as the v-SNA RE during fusion of 
tubular transport intermediates with maturing melanosomes. 
Importantly, we also describe a distinct tubular pathway to re-
trieve VAMP7 from melanosomes after cargo delivery and show 
that this pathway requires BLOC-3. Our data provide the first 
evidence of SNA RE recycling from a LRO, provide new in-
sights into SNA RE recycling in the late endosomal system in 
mammalian cells, and identify a novel membrane trafficking 
step in melanocytes that is regulated by BLOC-3.
Results
VAMP7 localizes to melanosomes and is 
required for melanosome cargo trafficking 
and pigmentation
VAMP7 is thought to localize to melanosomes and to be re-
quired for melanogenesis (Tamura et al., 2011; Yatsu et al., 
2013; Jani et al., 2015). We first confirmed the localization of 
VAMP7 in immortal mouse melanocytes derived from C57BL/6 
mice (melan-Ink4a [wild type {WT}] or melan-a; Bennett et al., 
1987; Sviderskaya et al., 2002). When expressed in WT mouse 
melanocytes, EGFP-tagged VAMP7 (GFP-VAMP7) localized 
by fluorescence microscopy (FM) extensively to pigmented 
melanosomes in the cell periphery (82 ± 6%; n = 13 cells), and 
marked pigment granules more predictably (P < 0.0001) than 
the melanosomal cargo protein TYRP1 (65 ± 12% overlap; 
n = 13 cells) with which VAMP7 partially overlapped (Fig. 1, 
a–c). Immuno-EM using immunogold labeling on ultrathin 
cryosections of transfected WT melan-a cells confirmed that 
GFP-VAMP7 localizes to the limiting membrane of pigmented 
melanosomes and adjacent vesicular structures (Fig. 1 d, arrows). 
To identify the specific cargo trafficking defect in VAMP7- 
deficient cells, we depleted VAMP7 in human MNT-1 melanoma 
cells by siRNA-mediated knockdown (Fig. 1 e). Consistent with 
previous observations by bright-field (BF) microscopy (Yatsu et 
al., 2013; Jani et al., 2015), analysis by standard EM showed that 
VAMP7-depleted MNT-1 cells harbored fewer fully pigmented 
stage IV melanosomes and less overall pigmentation than control 
siRNA-treated MNT-1 cells (Fig. 1, f–h). Quantification of immu-
nogold labeling by immuno-EM showed that whereas TYRP1 lo-
calizes predominantly to melanosomes in control siRNA-treated 
MNT-1 cells, a large cohort is mislocalized to tubulovesicular 
endosomes adjacent to melanosomes in VAMP7-depleted cells 
(Fig. 1, i–k, arrowheads). These data support a role for VAMP7 
in pigmentation by trafficking melanosomal cargoes such as 
TYRP1 from endosomes to maturing melanosomes.
VAMP7 traffics to melanosomes in  
BLOC-1–dependent tubular carriers
To determine whether VAMP7 traffics to melanosomes via 
BLOC-1–independent or –dependent pathways, we analyzed 
GFP-VAMP7 localization in BLOC-1–deficient (BLOC-1−/−) 
melanocytes relative to melanosomal cargoes and the pan-
early endosomal SNA RE syntaxin 13 (STX13; also known as 
syntaxin 12) by FM. In melanocyte cell lines (melan-pa and 
melan-mu) from two different BLOC-1−/− mouse models (pallid 
and muted), GFP-VAMP7 was retained (79 ± 7% in melan-pa; 
n = 53 cells) in sorting and recycling endosomes, marked by 
expression of mCherry-STX13 (mCh-STX13; Fig.  2, a–e, 
arrowheads; and Fig. S1, f–i, arrowheads; compare to WT in 
Fig. S1, a–e, arrows) to an even higher extent (P < 0.0001) than 
the BLOC-1–dependent melanosome cargo TYRP1 (66 ± 14% 
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in melan-pa; Setty et al., 2007). Melanosomal localization of 
GFP-VAMP7 was restored by stable expression of the missing 
Pallidin or Muted subunits (melan -pa :MycPa or BLOC-1R and 
melan -mu :MuHA rescue) before GFP-VAMP7 expression 
(Fig.  2, f–j; and Fig. S1, j–m). VAMP7 mislocalization in 
BLOC-1−/− cells does not reflect global VAMP mistrafficking, 
as localization of VAMP2, VAMP4, and VAMP8 was unaffected 
in BLOC-1−/− cells compared with WT melanocytes (Fig.  2, 
k–p). Together, these data suggest that VAMP7 is a BLOC-1–
dependent melanosome cargo.
To test whether VAMP7 is targeted to melanosomes in 
BLOC-1–dependent tubular carriers, we exploited the endosomal 
retention of VAMP7 in BLOC-1−/− cells. BLOC-1–dependent 
cargo trafficking in real time is difficult to study in WT melano-
cytes, as cargoes such as TYRP1 are localized largely to mature 
pigmented melanosomes at steady state (Orlow et al., 1993; Vi-
jayasaradhi et al., 1995; Setty et al., 2007) and thus the fraction of 
TYRP1 actively trafficking to melanosomes is small and difficult 
to detect. Because stable reexpression of Pallidin in BLOC-1−/− 
melan-pa melanocytes restores GFP-VAMP7 localization to mel-
anosomes, we surmised that analysis of melan-pa cells soon after 
transient expression of Pallidin might allow us to visualize early 
BLOC-1–dependent transport events. We thus cotransfected 
melan-pa cells with myc-Pallidin, GFP-VAMP7, and mCh-
STX13 and analyzed fixed cells by FM at various times after 
transfection (Fig. 2, q–v). We observed a time-dependent decrease 
in the extensive overlap between GFP-VAMP7 and mCh-STX13 
in endosomes (arrowheads) and a concomitant increase in GFP-
VAMP7–labeled structures that lacked mCh-STX13 (arrows). 
This GFP-VAMP7 redistribution required BLOC-1 function, 
as it was not observed upon cotransfection of Pallidin-deficient 
melan-pa cells with an excess of the Muted subunit (Fig. 2, q, u, 
and v; and Fig. 3, a–d and m–p), which does not restore BLOC-1 
expression (Setty et al., 2007). The GFP-VAMP7–containing, 
mCh-STX13–negative structures were newly generated matur-
ing melanosomes that had not yet accumulated pigment, because 
they contained TYRP1 (Fig. 3, e–l, arrows) and the early-stage 
melanosome marker PMEL (Fig. 3, q–t, arrows).
Like the early endosomes from which they derive, the 
BLOC-1–dependent tubular carriers through which cargoes 
such as TYRP1 are transferred to melanosomes, but not mel-
anosomes themselves, were labeled by GFP- or mCh-STX13 
(Setty et al., 2007; Delevoye et al., 2009, 2016; Dennis et al., 
2015). To test whether VAMP7 is transported through these 
carriers, we analyzed melan-pa melanocytes 20 h after cotrans-
fection with myc-Pallidin, GFP-VAMP7, and mCh-STX13. 
Figure 1. VAMP7 localizes to melanosomes 
and is required for pigmentation and cargo 
trafficking. (a–c) WT melan-Ink4a melanocytes 
transiently expressing GFP-VAMP7 (green) 
were fixed and labeled for TYRP1 (red) and 
analyzed by deconvolution immuno-FM. Bar, 
10 µm. BF (melanin) image in c is pseudoco-
lored blue in insets. Insets of boxed regions 
are magnified five times; bar, 1 µm. Melano-
somes labeled by both VAMP7 and TYRP1 
(arrowheads) or VAMP7 only (arrow) are indi-
cated. (d) Ultrathin cryosection of WT melan-a 
melanocytes transfected with GFP-VAMP7 and 
labeled for VAMP7 with 10 nm protein A gold 
(PAG10). Arrows show GFP-VAMP7 on stage 
IV melanosomes (IV) and adjacent vesicles. 
Bar, 200 nm. (e–k) MNT-1 melanoma cells 
treated with control (siCTRL) or VAMP7-specific 
siRNA (siVAMP7) were analyzed 5 d later. (e) 
Whole-cell lysates fractionated by SDS-PAGE 
were immunoblotted for VAMP7 or the AP-1 
subunit γ-adaptin as a control. Relevant bands 
and positions of nearby molecular weight 
markers are shown. (f and g) Thin sections of 
fixed cells in epon were analyzed by conven-
tional EM. Bars, 500 nm. (h) Melanin content 
in cell lysates was assayed by spectropho-
tometry. Data are normalized to siCTRL and 
represent mean ± SD from at least three exper-
iments. (i and j) Ultrathin cryosections of fixed 
cells were labeled for TYRP1 with PAG10. 
Asterisks show pigmented melanosomes, and 
arrowheads show TYRP1 labeling on melano-
somal membrane or closely adjacent vesicular 
structures. Bars, 200 nm. (k) Quantification 
of TYRP1 localization in siCTRL and siVAMP7 
cells (mean ± SD from three measurements). 
Golgi/TGN, Golgi and trans-Golgi network; 
Lyso, lysosomes; Melan, melanosomes; MVBs, 
multivesicular bodies; TVE endo, tubulovesic-
ular endosomes associated with endosomes; 
TVE Melan, tubulovesicular endosomes asso-
ciated with melanosomes; Vac Endo, vacuolar 
endosomes; Vesicle, other vesicular structures. 
*, P < 0.05; **, P < 0.01; ***, P < 0.005; 
n.s., no significant difference.
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In such transiently rescued BLOC-1−/− cells, unlike in WT or 
stably rescued BLOC-1R cells in which mCh-STX13 is largely 
segregated from GFP-VAMP7 and TYRP1-GFP (Fig.  4, a–f; 
Fig. S2, a and b; and Videos 1 and 2), tubules emerging from 
mCh-STX13-labeled endosomes that contain both mCh-STX13 
and either GFP-VAMP7 (Fig. 4, g–j, arrows; and Video 3) or 
TYRP1-GFP (Fig. 4, k–n, arrows; and Video 4) were readily 
visualized. In contrast, in control mock rescued cells express-
ing Muted-HA, STX13 tubule formation was dramatically 
impaired (as quantified in Delevoye et al., 2016) and GFP-
VAMP7 was retained in mCh-STX13–positive vacuolar en-
dosomes (Fig. S2, c–f, arrowheads; and Video 5). These data 
provide direct evidence that both melanosomal cargoes and 
VAMP7 traffic from early endosomes to melanosomes via 
STX13-containing tubules. Given the role of VAMP7 in TYRP1 
delivery to melanosomes (Fig. 1), we conclude that VAMP7 likely 
functions in fusion of BLOC-1–dependent endosomal carriers 
with maturing melanosomes.
VAMP7 recycles from melanosomes in 
tubular carriers that lack STX13
If VAMP7 functions as a canonical v-SNA RE in the fusion of 
endosomal transport carriers with maturing melanosomes, it 
must be retrieved from melanosomes for use in future rounds of 
cargo delivery. Consistently, we observed GFP-VAMP7–labeled 
structures emanating from pigmented melanosomes by live-cell 
fluorescence and BF microscopy of WT melanocytes (Figs. 5, 
a–c; Fig. S2 i; and Video 6). The GFP-VAMP7–labeled tubules 
(arrows) were distinct from the anterograde mCh-STX13– 
labeled tubules (arrowheads) that deliver cargo to melanosomes, 
as assessed by dual-color imaging (Fig. 5, d–g; and Video 1). This 
subpopulation of GFP-VAMP7–positive, melanosome–derived 
tubules were independent of, and shorter in length and less 
stable than, those labeled solely by mCh-STX13 (P < 0.0001, 
n = 50 tubules each; Fig. S2, g and h). The GFP-VAMP7 tu-
bules that exit melanosomes did not contain detectable 
mRFP-tagged OCA2 or TYRP1 (Fig. 5, h–j; Fig. S2, k–n; and 
Figure 2. VAMP7 is a BLOC-1 cargo. (a–j) 
BLOC-1–deficient melan-pa (BLOC-1−/−; a–e) 
or “rescued” melan-pa cells stably expressing 
myc-Pallidin (BLOC-1R; f–j) and transiently ex-
pressing GFP-VAMP7 (green) and mCh-STX13 
(red) were fixed and labeled for TYRP1 (cyan) 
and analyzed by deconvolution immuno-FM. 
Arrowheads show GFP-VAMP7 and TYRP1 
retained in mCh-STX13–positive endosomes, 
and arrows show melanosomes with GFP-
VAMP7 and TYRP1 but lacking mCh-STX13. In-
sets of boxed regions are magnified five times. 
(k–m) WT melan-Ink4a (n–p) and BLOC-1– 
deficient melan-pa (BLOC-1−/−) transiently ex-
pressing GFP-VAMP2 (green) and mCh-STX13 
(red, k and n), VAMP4-HA (green, l and o), 
or GFP-VAMP8 (green, m and p) were fixed, 
labeled for HA (green) and Giantin (red, l and 
o) or for LAMP1 (red, m and p), and analyzed 
by deconvolution immuno-FM. Merged images 
are shown with BF images pseudocolored 
blue. Dashed line in o indicates cell borders. 
Insets are boxed regions magnified six times. 
(q–v) BLOC-1−/− melan-pa melanocytes tran-
siently transfected with GFP-VAMP7 (green), 
mCh-STX13 (red), and either myc-Pallidin (“res-
cue”) or myc-Muted (“mock rescue”) for indi-
cated times. Arrowheads show GFP-VAMP7 
retained in mCh-STX13 endosomes; and ar-
rows point to GFP-VAMP7 in melanosome pre-
cursors. Note that pigmentation is not detected 
until ∼72  h after transfection with myc-Palli-
din. Insets are boxed regions magnified 3.5 
times. (u) Quantification (mean ± SD from 15 
regions of at least nine cells per time point rep-
resenting three independent experiments) of 
GFP-VAMP7–labeled structures that lack mCh-
STX13 in rescue and mock rescue cells at 12, 
24, and 48 h after transfection. (v) Area (mean 
± SD from at least 15 cells per time point rep-
resenting four independent experiments) of 
overlap between GFP-VAMP7 and mCh-STX13 
in the periphery of mock rescue and rescue 
cells quantified at 12, 24, and 48 h after trans-
fection. **, P < 0.01; ****, P < 0.0001. BF 
images in d, I, and k–t are pseudocolored blue 
in merge. Bars: (a–t) 10 µm; (insets) 2 µm.
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Videos 7 and 8), suggesting that they were selective for cargo 
destined for removal from melanosomes. Thus, GFP-VAMP7 
labels membrane transport carriers that emerge from maturing 
melanosomes with characteristics of those that recycle SNA REs 
(Bonifacino and Glick, 2004; Jahn and Scheller, 2006).
VARP is associated with VAMP7 recycling 
tubules and is recruited to melanosomes by 
RAB38 and VAMP7
VAMP7 contains an autoinhibitory longin domain that can block 
VAMP7 interactions with cognate SNA REs (Martinez-Arca et 
al., 2003). The scaffolding protein VARP binds both the longin 
and SNA RE domains of VAMP7 (Burgo et al., 2009), keeping 
VAMP7 in an autoinhibited conformation and impeding its 
fusogenic activity (Schäfer et al., 2012). VARP was proposed 
to support melanosome biogenesis via its ability to bind to 
VAMP7 (Tamura et al., 2009) and to mediate endosomal recy-
cling in non-LRO–containing cells (Hesketh et al., 2014). Thus, 
we tested whether VARP associates with VAMP7 retrieved from 
melanosomes. When expressed in WT melanocytes, GFP- or 
HA-tagged VARP localized in part (30% ± 6%) to puncta ad-
jacent to melanosomes in the cell periphery (Fig. 6, a–f), and 
in part (70% ± 6%) to endosomal structures, as in nonmela-
nocytic cells (Hesketh et al., 2014), that predominated in the 
perinuclear region (Fig. 6, g–i). By spinning-disk microscopy 
analysis of WT melanocytes, VARP-GFP was detected on 
nearly all mCh-VAMP7 tubulovesicular structures (arrows) 
that exited from melanosomes (arrowhead) in the cell periphery 
(Figs. 6, j–l; Fig. S3 a; and Video 9). Like the VAMP7-labeled 
tubules, VARP-GFP–labeled tubules were not enriched for the 
melanosomal cargoes TYRP-mRFP or mRFP-OCA2 (Figs. 6, 
m–o; Fig. S3, b and e–h; and Videos 10 and 11). These results 
place VARP on the VAMP7-containing tubules that exit mel-
anosomes, where VARP might stabilize VAMP7 in a nonfu-
sogenic state. VARP-GFP–labeled tubules also extended from 
mCh-STX13–labeled endosomes in the perinuclear region 
(Fig. 6, p–r; Fig. S3 c; and Video 12), but they were distinct 
from the STX13-labeled tubules that traffic cargo to melano-
somes (Fig. 6, s–u; Fig. S3 d; and Video 12) and likely represent 
carriers that recycle cargoes such as GLUT-1 to the cell surface 
(Hesketh et al., 2014) or that mediate retrograde endosome to 
TGN trafficking (Wassmer et al., 2009).
In addition to VAMP7, VARP binds to RAB32/38 and the 
VPS29/35 subunits of the retromer complex via distinct sites 
(Zhang et al., 2006; Wang et al., 2008; Burgo et al., 2009; Ta-
mura et al., 2009; Hesketh et al., 2014; McGough et al., 2014) 
and functions as a RAB21 GEF (Zhang et al., 2006). In non-
melanocytic cells, retromer binding is required to recruit VARP 
to endosome-derived tubules, and both retromer and VARP 
participate in GLUT-1 trafficking to the cell surface (Hesketh 
et al., 2014; McGough et al., 2014). In melanocytes, TYRP1 
localization to melanosomes requires both retromer (McGough 
et al., 2014) and VARP binding to VAMP7 and RAB32/38, but 
not RAB21 GEF activity (Tamura et al., 2011). Like VAMP7, 
RAB38 and RAB32 localize in part to melanosomes (Wasmeier 
et al., 2006; Bultema et al., 2012; Gerondopoulos et al., 2012). 
Figure 3. VAMP7 traffics with TYRP1 to maturing mela-
nosomes upon BLOC-1 rescue. (a–t) BLOC-1−/− (melan-pa) 
cells transiently transfected with GFP-VAMP7 (green), mCh-
STX13 (red), and either myc-Pallidin (BLOC-1R) or myc-Muted 
(BLOC-1−/−C) were fixed 12 or 24 h after transfection. Cells 
were then immunolabeled for TYRP1 (blue, a–l) or PMEL 
(blue, m–t) and analyzed by deconvolution immuno-FM. Ar-
rowheads show GFP-VAMP7 and TYRP1 (a–l) or GFP-VAMP7 
alone (m–t) retained in mCh-STX13–labeled endosomes, 
and arrows point to GFP-VAMP7 and either TYRP1 (a–l) or 
PMEL (m–t) colabeled in melanosomal precursors that lack 
mCh-STX13. Insets are boxed regions magnified five times. 
Bars: (main) 10 µm; (insets) 2 µm.
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Indeed, GFP-RAB38 overlapped by FM with VARP-HA on 
puncta adjacent to melanosomes (Fig. 7, a–h) and, like VARP, 
GFP-RAB38 was detected on mCh-VAMP7–containing tu-
bules that exit melanosomes (Fig. 7, i–l; and Video 13). There-
fore, we investigated the requirement for VAMP7, RAB32/38, 
and retromer in recruiting VARP to melanosomes by exploiting 
VARP site-directed mutants in which binding to each partner 
is impaired (Hesketh et al., 2014). We expressed GFP-tagged 
full-length VARP or site-directed mutants in WT melanocytes 
and quantified GFP-positive puncta that associated with pig-
mented melanosomes (arrowheads) or with mCh-STX13–la-
beled endosomes (Fig. 8, a–g, arrows). Mutagenesis of either 
the VAMP7 or the RAB32/38 binding site resulted in decreased 
VARP localization to melanosomes by 57% ± 18% or 60% ± 
19%, respectively, and loss of both binding sites led to a further 
reduction (87% ± 11% less than WT). However, as in nonpig-
mented cells (Hesketh et al., 2014), these mutations had no 
effect on VARP association with mCh-STX13–labeled early 
endosomes. In contrast, mutagenesis of the retromer binding 
site had no effect on melanosome localization but severely im-
paired the association of VARP with mCh-STX13 endosomes 
as in nonmelanocytic cells (Hesketh et al., 2014). Thus, VARP 
recruitment to pigmented melanosomes depends primarily on 
interactions with both VAMP7 and RAB32/38, with which it 
associates in retrograde transport carriers, and does not re-
quire binding to retromer.
BLOC-3 is required for RAB38 and VARP 
recruitment to melanosomes and facilitates 
formation of VAMP7 recycling tubules
BLOC-3, composed of HPS1 and HPS4 subunits that are de-
fective in the majority of HPS patients (Seward and Gahl, 
2013), is a GEF for RAB32 and RAB38 (Gerondopoulos et al., 
2012), but the effects of BLOC-3 mutations on melanosome 
biogenesis are unclear and vary in different pigment cell types 
(Gardner et al., 1997; Nguyen et al., 2002; Richmond et al., 
2005; Nguyen and Wei, 2007; Gerondopoulos et al., 2012). 
Like BLOC-3–deficient hair bulb melanocytes (Nguyen et al., 
2002) and primary mouse melanocytes (Gardner et al., 1997), 
immortal BLOC-3–deficient melan-le (from HPS4-deficient 
light ear mice) and melan-ep (from HPS1-deficient pale ear 
mice) melanocytes harbor abundant pigmented melanosomes, 
some of which are unusually large (Fig. 9, c, l, and u; Fig. S4, 
g, k, and o; and Fig. S5, c, k, o, and w). The extent of TYRP1 
localization to pigment granules in these cells was only slightly 
reduced relative to WT melanocytes (Fig. 9, a–h; and Fig. S4, 
a–d; 66% ± 6% of TYRP1 overlapped with pigment granules 
in WT melan-a cells, 56% ± 8% in melan-le; difference is not 
statistically significant); similarly, segregation of the lysosomal 
membrane protein LAMP2 from pigment granules was only 
slightly impaired (Fig. 9, a–h; and Fig. S4, a–d; 5% ± 3% of 
LAMP2 overlapped with pigment granules in WT melan-a 
cells, 14% ± 5% in melan-le; P = 0.003). These data indicate 
that BLOC-3 is not directly responsible for anterograde cargo 
trafficking to melanosomes or for gross melanosome segrega-
tion from the endolysosomal system. We thus tested whether 
BLOC-3 deficiency affected RAB38 and VARP localization 
and VAMP7 recycling. Consistent with BLOC-3 function as 
a RAB38 GEF, GFP-RAB38 in HPS4-deficient melan-le cells 
was largely diffuse and did not associate with pigment granules 
(Fig. 9, i–m). Accordingly, VARP localization to melanosomes 
was also substantially reduced in melan-le cells (Fig. 9, s–v). 
Stable reexpression of a WT HPS4 subunit in HPS4-deficient 
melan-le melanocytes, but not of excess WT HPS1, restored 
Figure 4. VAMP7 and TYRP1 traffic to mel-
anosomes in BLOC-1–dependent membrane 
tubules. (a–f) WT melan-Ink4a cells transiently 
transfected with mCh-STX13 (red) and either 
TYRP1-GFP (green, a–c; cell shown in Fig. S2 a) 
or GFP-VAMP7 (green; d-f; cell shown in Figs. 
5 d and S2 b) were analyzed 24 h later by 
spinning-disk confocal microscopy at 1 fps. 
Regions from a single frame are shown. Ar-
rows, mCh-STX13-labeled endosomal tubules; 
arrowheads, TYRP1-GFP-labeled melanosome 
(a–c) or GFP-VAMP7-labeled tubule (d-f). Note 
that tubular mCh-STX13–labeled endosomes 
in live-cell analyses appear punctate upon fix-
ation (e.g., Fig.  2, g, s, and t). Bar, 1 µm. 
(g–n) melan-pa melanocytes were transiently 
transfected with myc-Pallidin, mCh-STX13 and 
either GFP-VAMP7 (g–j) or TYRP1-GFP (k-n) 
and analyzed 20 h later by spinning-disk con-
focal microscopy at ∼1 fps. (g and k) Single 
frames of representative cells showing overlap 
of mCh-STX13 with GFP-VAMP7 (g) or TYRP1-
GFP (k). Bars, 10 µm. Image sequences from 
the boxed regions in g and k are magnified 
five times in h–j and l–n, respectively. Arrows 
show mCh-STX13–labeled tubules contain-
ing GFP-VAMP7 (h–j) or TYRP1-GFP (l–n). 
Elapsed time (in seconds) is indicated at the 
lower right. Bars, 1 µm.
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both RAB38 and VARP melanosomal localization to WT lev-
els (Fig. 9, n–r and w–z; and Fig. S4, i–p). Similar data were 
obtained using HPS1-deficient melan-ep melanocytes and sta-
ble reexpression of “rescuing” HPS1 or “nonrescuing” HPS4 
(Fig. S5, a–x). Thus, BLOC-3 activation is required for the re-
cruitment and/or stabilization of RAB38 on/to melanosomes 
and for subsequent effective VARP recruitment.
To test whether BLOC-3 is required for VAMP7 recycling, 
we quantified the fission of GFP-VAMP7–containing tubules 
from melanosomes by live imaging of transiently transfected 
WT melanocytes, HPS4-deficient melan-le (le), or melan-le 
cells stably expressing either HPS1 (le :HPS1) or HPS4 (le : 
HPS4). As in WT melanocytes, the majority of GFP-VAMP7 
(78% ± 9%, n = 23 cells; not significantly different from WT) 
localized to melanosomes in the periphery of melan-le cells 
(Fig.  9  j). However, whereas GFP-VAMP7–labeled tubules 
were frequently observed emanating from these structures 
in WT cells (Fig.  10, a and d; and Video  14), such tubules 
were rare in melan-le cells (Fig. 10, b and d). Restoration of 
BLOC-3 function by stable expression of HPS4 restored WT 
tubule frequency, whereas stable expression of HPS1 did not 
(Fig. 10, c and d). Thus, BLOC-3 regulates recycling of VAMP7 
from melanosomes, most likely by recruiting RAB38 and 
consequently VARP to initiate and/or complete tubule formation.
Discussion
VAMP7 has been implicated in melanosome biogenesis (Ta-
mura et al., 2011; Jani et al., 2015), but the pathways by which 
it is directed toward and recycled from melanosomes were 
unknown. Here, we show that VAMP7 functions during mel-
anosome biogenesis primarily as a v-SNA RE in BLOC-1– 
dependent tubular transport from endosomes to melanosomes 
and thereby promotes melanosomal delivery of BLOC-1– 
dependent cargoes such as TYRP1. Importantly, our analyses 
of VAMP7 dynamics revealed a previously undocumented 
SNA RE retrieval pathway from maturing melanosomes. This 
pathway employs membrane tubules that emerge from melano-
somes at sites enriched in RAB38 and VARP and that require 
the RAB32/38 GEF BLOC-3 for their formation. The resulting 
model (Fig.  10  e) has important implications for RAB32/38, 
BLOC-3, and VAMP7 function in the biogenesis of other LROs 
and in the etiology of the most common forms of HPS.
Cargoes are delivered to melanosomes by two distinct 
pathways that emerge from early endosomes: one that requires 
BLOC-1 and a second that is BLOC-1 independent (Sitaram 
and Marks, 2012). Our data using a novel transient rescue 
assay place VAMP7 on the BLOC-1–dependent pathway that 
also delivers melanosomal cargoes such as TYRP1 and OCA2. 
That VAMP7 is a cargo of the BLOC-1 pathway is consistent 
with the reduced VAMP7 levels in lysates of BLOC-1–deficient 
fibroblasts and 293T cells and in synaptic vesicle fractions 
of BLOC-1–deficient neurons (Salazar et al., 2006; Ryder et 
al., 2013). The altered TYRP1 distribution in cells depleted 
of VAMP7 indicates that VAMP7 likely functions as the main 
v-SNA RE for cargo delivery in this pathway. Given that STX13 
labels the BLOC-1–dependent transport intermediates (Dennis 
et al., 2015), this function for VAMP7 likely explains the re-
ported requirement for VAMP7 in the accumulation of truncated 
STX13 on melanosomes (Jani et al., 2015). VAMP7 might sim-
ilarly facilitate fusion of tubular intermediates between endo-
somes and lysosomes in cell types that lack LROs (Bright et al., 
2005); formation of such tubules, like a subclass of recycling 
endosomes (Delevoye et al., 2016), might require BLOC-1 or 
the structurally related BORC (Pu et al., 2015).
v-SNA REs are thought to cycle back to their membrane of 
origin after cargo delivery to mediate additional rounds of cargo 
trafficking (Bonifacino and Glick, 2004; Jahn and Scheller, 
2006). However, to our knowledge, the only described pathway 
for v-SNA RE retrieval in the late endosomal system in mam-
malian cells is the Hrb-dependent recycling of VAMP7 from the 
plasma membrane after fusion with late endosomes (Pryor et al., 
Figure 5. GFP-VAMP7 exits melanosomes in STX13-independent tubules 
lacking TYRP1. (a–f) WT melan-Ink4a melanocytes transiently transfected 
with GFP-VAMP7 alone (green, a–c) or with mCh-STX13 (red, d–g) or 
TYRP1-mRFP (red, h–j) were analyzed 24 h later by spinning-disk confo-
cal microscopy at ∼1 fps. (a–c) Image sequence from a cell (shown in 
Fig. S2 i) expressing GFP-VAMP7 relative to melanosomes visualized by 
BF microscopy. Arrow shows a GFP-VAMP7 tubule, and the arrowhead 
points to a melanosome in the BF image. Bar, 2 µm. (d) Single frame from 
representative cell expressing GFP-VAMP7 and mCh-STX13. Bar, 10 µm. 
(e–g) Single frames from boxed regions in d with single channels and 
merged image. Arrows show tubules labeled by GFP-VAMP7 (green), and 
arrowheads show tubules labeled by mCh-STX13 (red). Bar, 1 µm. Insets 
are magnified two times from d. (h–j) Image sequence from a cell (shown 
in Fig. S2 j) expressing GFP-VAMP7 (green) and TYRP1-mRFP (red). A GFP-
VAMP7–labeled tubule (arrow) emerges from a TYRP1-mRFP/GFP-VAMP7–
labeled melanosome (arrowhead). Elapsed time is shown in seconds (s) 
at the bottom. Bar, 2 µm.
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Figure 6. A cohort of VARP localizes to mel-
anosomes and accompanies GFP-VAMP7 on 
departing tubules. (a–i) WT melan-Ink4a me-
lanocytes transiently transfected with VARP-
GFP and mCh-VAMP7 (a–c), GFP-VAMP7 and 
VARP-HA (d–f), or VARP-GFP and mCh-STX13 
(g–i) were fixed 48 h later, labeled with an-
ti-HA (d–f), and analyzed by deconvolution 
immuno-FM. BF images are pseudocolored 
blue and shown in merge and insets (boxes 
magnified five times). Arrowheads show VARP 
puncta adjacent to melanosomes (a–f) or to 
mCh-STX13–labeled endosomes (g–i). Bars: 
(main), 10 µm; (insets), 2 μm. (j–u) WT melan-
Ink4a melanocytes transiently transfected with 
VARP-GFP and either mCh-VAMP7 (j-l; see Fig. 
S3 a), mRFP-OCA2 (m–o; see Fig. S3 b) or 
mCh-STX13 (p–u; see Fig. S3, c and d) were 
analyzed 48  h later by spinning-disk confo-
cal microscopy at ∼1 fps. Elapsed time (in 
seconds) is indicated at lower right. (j–l) A 
VARP-GFP– and mCh-VAMP7–labeled tubule 
(arrow) extends from a melanosome (arrow-
head). (m–o) A VARP-GFP–labeled vesicle 
(arrow) exits from an mRFP-OCA2–labeled 
melanosome (arrowhead). (p–r) A VARP-GFP 
tubule (arrow) departs from a mCh-STX13–
labeled endosome (arrowhead). (s–u) A 
mCh-STX13 tubule (arrow) exits from a mCh-
STX13/VARP-GFP double-labeled endosome 
(arrowhead). Bars, 2 µm.
Figure 7. RAB38 overlaps with VARP on mel-
anosomes and accompanies GFP-VAMP7 on 
departing tubules. (a–l) WT melan-Ink4a cells 
transiently transfected with GFP-RAB38 (green) 
and either VARP-HA (red, a–d), or mCh-
VAMP7 (red, e–l) were analyzed 48 h later. 
(a–h) Cells were fixed, labeled with anti-HA 
(a–d), and analyzed by deconvolution immu-
no-FM. BF images are pseudocolored blue in 
merge and insets (boxed regions magnified 
five times). (a–d) Arrowheads show VARP-HA 
and GFP-RAB38 puncta adjacent to melano-
somes. (e–h) Arrowheads show GFP-RAB38 
and mCh-VAMP7 localized to melanosomes. 
(i–l) Cells were analyzed by spinning-disk 
confocal microscopy at ∼1 fps. (j–l) Image se-
quence of boxed region in i, magnified five 
times; elapsed time (in seconds) is indicated at 
the lower right. A mCh-VAMP7/GFP-RAB38–
labeled structure (arrowhead) emerges from 
a mCh-VAMP7–labeled melanosome (arrow). 
Bars: (main) 10 µm; (insets and j–l) 2 µm.
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2008). Here, we visualized the retrieval of VAMP7 from mela-
nosomes in small tubular intermediates. Melanosomal cargoes 
were not enriched in these tubules, indicating that the tubules 
are cargo selective. VARP association with these tubules implies 
that VAMP7 within them is bound to VARP and thus inactive 
(Schäfer et al., 2012), as expected for a recycling v-SNA RE. 
We speculate that VARP is released before fusion with the tar-
get, allowing VAMP7 to serve as a v-SNA RE during recycling. 
We could not visualize the target compartment of these rapidly 
motile tubules by single-plane spinning-disc microscopy, but 
we speculate that they ultimately return VAMP7 to STX13- 
containing early endosomes either directly or via late endosomes 
or the plasma membrane. It is also unclear how cargo is selected 
for entry into the tubules but AP-3, which engages VAMP7 on 
early endosomes (Martinez-Arca et al., 2003; Kent et al., 2012) 
and was recently suggested to facilitate STX13 recycling from 
melanosomes (Jani et al., 2015), is unlikely to participate in this 
process, as VAMP7 is localized normally in AP-3–deficient me-
lanocytes (unpublished data). VARP itself might sort VAMP7 
into the tubules; testing this model will require reconstitution 
of VARP-deficient melanocytes with specific binding mutants.
The dramatic depletion of VAMP7-containing recycling 
tubules in cells lacking BLOC-3 suggests that RAB38 and/or 
RAB32 play an important role in recruiting effectors for cargo 
selection, tubule formation, and/or tubule release. One such 
effector might be the RAB32/38 binding partner myosin Vc 
(Bultema et al., 2014), which might primarily mediate recy-
cling tubule dynamics with secondary effects on melanosome 
secretion (Bultema et al., 2014). RAB38 and VAMP7 might in-
directly engage other recycling effectors via VARP, akin to the 
recruitment of the kinesin-1 motor KIF5 by VARP in neurons 
(Burgo et al., 2012). The ubiquitously expressed BLOC-3 (Chi-
ang et al., 2003; Martina et al., 2003; Nazarian et al., 2003) 
might facilitate VAMP7 retrieval from other organelles in cell 
types that lack LROs, perhaps through activation of trace levels 
of RAB32 or RAB38 or of a distinct RAB. Note that although 
binding to retromer was not required for VARP recruitment to 
melanosomes, our data do not negate a role for retromer in ei-
ther anterograde or retrograde transport as recently proposed 
(McGough et al., 2014).
Although BLOC-3 clearly functions as a GEF for RAB32 
and RAB38 (Gerondopoulos et al., 2012), the physiological 
roles of BLOC-3 and its target RABs during melanosome bio-
genesis were unknown. Simultaneous depletion of RAB32 and 
RAB38 (Loftus et al., 2002; Wasmeier et al., 2006; Bultema et 
al., 2012) or VARP (Tamura et al., 2009, 2011) in skin melano-
cytes resulted in pigment dilution and TYR and TYRP1 mislo-
calization largely to the Golgi and/or TGN. Similarly, retinal 
pigment epithelia (RPE) from RAB38-deficient chocolate mice 
are depleted of melanosomes and mislocalize a cohort of TYR 
(Lopes et al., 2007), and MNT-1 melanoma cells depleted of 
RAB32, RAB38, or BLOC-3 subunits are severely hypopig-
mented (Gerondopoulos et al., 2012). These data were inter-
preted as a direct role for these proteins in anterograde traffic, 
but they could also be explained by an indirect role through a 
failure of VAMP7 recycling and its resulting entrapment on mel-
anosomes; this would deplete VAMP7 from early endosomes 
with a consequent secondary failure in anterograde trafficking, 
as seen with VAMP7 knockdown (Tamura et al., 2011; Jani et 
al., 2015; Fig. 1). This model for a primary role for BLOC-3 
and RAB38 in retrograde transport would be consistent with the 
localization of RAB32 and RAB38 primarily to melanosomes 
Figure 8. VARP localizes to melanosomes 
by interaction with both VAMP7 and RAB38. 
(a–g) WT melan-Ink4a cells were transiently 
transfected with mCh-STX13 (red) and either 
WT VARP-GFP (green, a) or site-directed mu-
tants (green, b–e) with interfering mutations 
in the binding sites for VAMP7 (-VAMP7, b), 
RAB38 (-RAB38, c), both VAMP7 and RAB38 
(-V7, RAB38, d), or the VPS29 retromer sub-
unit (-retromer, e). Cells were fixed 48 h after 
transfection and analyzed by deconvolution 
FM; bar, 10 µm. Insets are boxed regions 
magnified five times. Bar, 2 µm. BF images 
are pseudocolored blue in merged images. 
Arrowheads show VARP-GFP puncta adjacent 
to melanosomes visualized by BF, and arrows 
point to VARP-GFP puncta adjacent to mCh-
STX13-labeled endosomes. (f) WT or mutant 
VARP-GFP puncta that were associated with 
melanosomes (visualized by BF; black bars) 
or with endosomes (labeled by mCh-STX13; 
gray bars) were quantified as mean ± SD from 
10 cells per VARP variant representing three 
independent experiments. (g) P-values for pair-
wise comparisons of melanosome-associated 
VARP puncta in f.  For endosome-associated 
VARP, only -V7 & R38 (P < 0.05 vs. WT) and 
-retromer (P < 0.0001 vs. all others) showed 
significant differences.
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(Bultema et al., 2012; Gerondopoulos et al., 2012; Fig. 7, a–h) 
and secondarily to tubulovesicular membranes (Wasmeier et al., 
2006) that might be retrograde, rather than anterograde, trans-
port intermediates. The reported interactions of RAB38 and 
RAB32 with the anterograde trafficking factors AP-1, BLOC-1, 
and BLOC-2 (Bultema et al., 2012) might coordinate antero-
grade and retrograde trafficking.
Intriguingly, a primary role for BLOC-3 and RAB32/38 
in VAMP7 recycling could also explain the variable phenotypes 
of pigment cells in BLOC-3–deficient mice (Gardner et al., 
1997; Nguyen and Wei, 2007) and HPS patients (Anderson et 
al., 2003; Takeuchi et al., 2014). In eyes of BLOC-3–deficient 
light ear or pale ear mice, RPE harbor few small, lightly 
pigmented melanosomes, whereas melanocytes of the adja-
cent choroid contain highly pigmented macromelanosomes 
(Gardner et al., 1997; Suzuki et al., 2002). Similarly, light 
ear and pale ear hair bulb melanocytes (like the immortal-
ized melan-ep and melan-le cells used here) harbor enlarged 
but otherwise normally pigmented melanosomes (Nguyen 
et al., 2002), whereas interfollicular skin melanocytes (like 
BLOC-3–depleted MNT-1 cells [Gerondopoulos et al., 2012] 
and HPS1 patient primary melanocytes [Boissy et al., 1998]) 
harbor fewer, small, hypopigmented melanosomes (Nguyen 
and Wei, 2007); these differences result in dark fur and light 
skin (Lane and Green, 1967). We speculate that these cell 
type–specific differences in melanosome biogenesis reflect 
different requirements for VAMP7 recycling in maintaining an 
endosomal pool of VAMP7 for anterograde transport. For ex-
ample, cell types with low levels of VAMP7 expression and/or 
high rates of melanosome biogenesis would deplete VAMP7 
from endosomes and hence block anterograde cargo traffick-
ing required for melanosome maturation, resulting in fewer, 
smaller and hypopigmented melanosomes. Alternatively, cell 
types with high levels of VAMP7 expression and/or low rates 
of melanosome biogenesis might restore sufficient levels of 
endosomal VAMP7 biosynthetically to compensate for the loss 
of recycling and permit sufficient anterograde cargo delivery 
for melanosome synthesis. The enlarged melanosomes in such 
cells would result from (1) continued anterograde membrane 
delivery without compensating retrograde membrane retrieval 
and (2) fusion of melanosomes with each other and with other 
organelles because of an excess of “unprotected” fusogenic 
VAMP7 lacking VARP. A similar rationale might explain the 
differences in melanosome biogenesis in the RPE and choroi-
dal melanocytes in RAB38-deficient chocolate mice (Brooks 
et al., 2007; Lopes et al., 2007) and, perhaps, the defect in 
TYRP1 localization in VARP-depleted melan-a cells (Tamura 
et al., 2009, 2011). Although future analyses of the rates of 
melanosome biogenesis and VAMP7 biosynthesis will be 
necessary to test these models, the identification of a VAMP7 
recycling pathway from melanosomes that is regulated by 
BLOC-3 provides a new way of thinking about an old problem.
Figure 9. VAMP7 and TYRP1, but not RAB38 and 
VARP, localize normally to melanosomes in BLOC-3–
deficient cells. (a–z) BLOC-3–deficient melan-le (le; 
a–d, i–m, and s–v) and “rescued” melan-le cells stably 
expressing HA-HPS4 (le :HPS4; e–h, n–r, and w–z) 
were untreated (a–h) or transiently transfected with 
mCh-VAMP7 (red, i–z) and either GFP-RAB38 (green, 
i–r) or VARP-GFP (green, s–z), fixed 24  h (a–r) or 
48 h (s–z) after transfection, and immunolabeled for 
LAMP2 (green, a–h) and/or TYRP1 (red, a–h; cyan, 
i–r) and analyzed by deconvolution immuno-FM. (a–h) 
Arrowhead points to a LAMP2-positive lysosome, 
and arrows show TYRP1-positive melanosomes. (i–r) 
Arrows show mCh-VAMP7 and TYRP1 colocalized 
to melanosomes visualized by BF. Note RAB38-GFP 
localization to melanosomes in le :HPS4 (n), but not in 
le (i). (s–z) Large arrowhead in le main panel (s) shows 
perinuclear accumulation of VARP-GFP. Arrowheads 
in insets show VARP-GFP puncta associated with 
melanosomes, and arrows point to melanosomes 
lacking VARP-GFP puncta. BF images in c, g, l, and q 
are pseudocolored blue in the merged images in d, h, 
m, and r. Insets, boxed regions magnified five times. 
Bars: (main) 10 µm; (insets) 2 µm.
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Materials and methods
Reagents
Chemicals were obtained from Sigma-Aldrich, except where noted. 
Hygromycin B was obtained from Roche. Tissue culture reagents 
and Lipofectamine 2000 were obtained from Invitrogen. Matri-
gel was obtained from BD.
Cell culture and generation of stable cells
Immortalized melanocyte cell lines melan-Ink4a-1 (also known as 
melan-Ink-4a-Arf-1; referred to here as melan-Ink4a or WT) derived 
from C57BL/6 Ink4a-Arf−/− mice (Sviderskaya et al., 2002), melan-ep1 
(referred to here as melan-ep) derived from BLOC-3–deficient 
C57BL/6J Hps1ep/ep pale ear mice and melan-le1 (referred to here as 
melan-le) derived from BLOC-3–deficient C57BL/6J Hps4le/le light ear 
mice (Suzuki et al., 2002; Chiang et al., 2003), and melan-pa1 (referred 
to here as melan-pa) derived from BLOC-1–deficient C57BL/6J- 
Pldnpa/pa pallid mice, melan-mu1 (referred to here as melan-mu) 
derived from BLOC-1–deficient B6 .CHMU /Le Mutedmu/mu muted mice, 
and stably transduced melan -pa :myc -Pa and melan -mu :MuHA lines 
in which BLOC-1 function is restored via expression of the missing 
subunit (Setty et al., 2007) have been previously described. All cells 
were cultured in RPMI 1640 medium supplemented with 10% FBS 
(Atlanta Biologicals) and 200 nM 12-O-tetradecanoylphorbol-13-
acetate. Melan-le, melan-ep, and stable lines derived from these cells 
were also cultured in the presence of 200 pM cholera toxin. Stably 
transduced cell lines were generated by infection with recombinant 
retroviruses produced in transiently transfected Plat-E cells (Morita 
et al., 2000) and selection with 100 µg/ml (for melan-ep based lines) 
or 150 µg/ml (for melan-le based lines) hygromycin B as described 
previously (Setty et al., 2007; Meng et al., 2012). Stable cell lines were 
occasionally treated with hygromycin B (100 or 150 µg/ml) to maintain 
selection for transgene expression. In most experiments, cells were 
transiently transfected with expression plasmids using Lipofectamine 
2000 (1  µl with 800 ng DNA, including carrier DNA as needed, in 
100  µl Opti-MEM for each coverslip in a 24-well plate or 4  µl 
Lipofectamine 2000 with 4 µg DNA in 500 µl Opti-MEM for 35-mm 
glass-bottom dishes) and imaged at varying times after transfection as 
indicated. Only cells with low or modest levels of transgene expression 
were chosen for analysis, and DNA amounts were titrated to ensure 
modest but detectable expression in 10–40% of transfected cells.
Antibodies
The following monoclonal antibodies were used: mouse anti-TYRP1 
(TA99) from ATCC; rat anti-LAMP1 (1D4B) and rat anti-LAMP2 
(GL2A7) from Developmental Studies Hybridoma Bank; mouse anti- 
PMEL (HMB-45) from Lab Vision; and mouse anti-HA.11 from 
Covance. Anti-VAMP7 mAb (158.2) and pAb (TG50) have previ-
ously been described and validated using Vamp7−/− mice (Danglot et 
al., 2012). Polyclonal rabbit antisera to STX13 (Prekeris et al., 1998) 
have been previously described, and rabbit anti-Giantin was purchased 
from Abcam (ab24586). Species-specific secondary antibodies from 
donkey conjugated to Alexa Fluor 488, 594, or 647 or Dylite 488, 594, 
or 647 used in immuno-FM were obtained from Jackson Immuno- 
Research Laboratories, Inc.
DNA constructs and siRNAs
The siRNAs used were human VAMP7 siRNA (5′-CTG CCA AGA 
CAG GAT TGT ATA-3′; Danglot et al., 2010) and control siRNA (5′-
AAT TCT CCG AAC GTG TCA CGT-3′). Recombinant retroviral vectors 
pBMN-X/N-IRES-Hygro-HA3-hHPS1 and pBMN-X/N-IRES-Hygro- 
HA3-hHPS4 encoding human HPS1 and HPS4 under the control of 
the Maloney mouse leukemia virus promoter were generated by sub-
cloning the XhoI–NotI cDNA fragment from pCI-HA3-humanHPS1 
and pCI-HA3-humanHPS4 (gifts from J.  Bonifacino, National In-
stitutes of Health, Bethesda, MD) into pBMN-X/N-IRES-Hygro. 
Figure 10. BLOC-3 is required to retrieve VAMP7 
from melanosomes. (a–d) WT melan-Ink4a (Ink4a; 
a), melan-le (le; b), melan -le :HPS1 (le :HPS1; not 
depicted), or melan -le :HPS4 (le :HPS4; c) cells 
transiently transfected with GFP-VAMP7 were 
analyzed by spinning-disk confocal microscopy 24 h 
later. Images were acquired at ∼1 fps and a segment 
of the image sequence is shown. Elapsed time (in 
seconds) is indicated at lower right. Bar, 2 µm. Arrows 
show GFP-VAMP7–labeled structures exiting GFP-
VAMP7–labeled melanosomes. (d) Fission of GFP-
VAMP7 transport intermediates from melanosomes 
was quantified by counting events within 26.5-µm2 
regions in the cell periphery during 5-min image 
sequences acquired at 1 fps. At least 15 regions from 
a minimum of six cells, representing three independent 
experiments, were quantified for each cell type; shown 
are mean values ± SD. ****, P < 0.0001. (e) Model 
for VAMP7 cycling during melanosome biogenesis.
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pCR3-mRFP-OCA2, pmCh-C1-STX13, pEGFP-C1-STX13, and 
pEGFP-N1-TYRP-EGFP (Dennis et al., 2015); pBMN-IRES-Hygro-
mycPa and pBMN-IRES-Hygro-mycMu (Setty et al., 2007); pLX-
IN-huVARP-HA2 (Schäfer et al., 2012); and pLXIN-huVARP-EGFP, 
pLXIN-huVARP(M684D,Y687S)-EGFP, pLXIN, huVARP(Q509A, 
Y550A)-EGFP, pLXIN-huVARP(H432S,L434A,H712S,L714A)-E
GFP, and pEGFP-N1-VARP(WT)-EGFP (Hesketh et al., 2014) have 
been previously described. pmRFP-N1-TYRP-mRFP was generated 
by amplifying mRFP from pmRFP-N1 by PCR and subcloning the 
resulting SalI–NotI fragment into pEGFP-N1-huTYRP1. pEGFP-C2-
RAB38 was a gift from A. Hume (University of Nottingham, Notting-
ham, England, UK). mCh-RAB38 controlled by the cytomegalovirus 
immediate early (CMV) promoter was generated by subcloning mCh 
into pEGFP-C2-RAB38 using the AgeI–XhoI region of mCh from 
pmCh-C1 (Takara Bio Inc.). pLXIN-VAMP4-HA (Gordon et al., 2009) 
was a gift from A. Peden (University of Sheffield, Sheffield, England, 
UK). EGFP-VAMP2, EGFP-VAMP7, and EGFP-VAMP8 in pEGFP-C 
vector, controlled by the CMV promoter and generated from rat cDNA, 
were gifts from P. Roche (National Institutes of Health, Bethesda, MD). 
pmCh-VAMP7 controlled by the CMV promoter was generated by sub-
cloning mCh into pEGFP-C-VAMP7 using the AgeI–BsrGI region of 
mCh from pmCh-C1 (Takara Bio Inc.).
EM
For conventional EM, MNT-1 cells were fixed with 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer (1.5 h on ice), postfixed with 1% 
OsO4/1.5% potassium ferricyanide (45 min on ice), dehydrated in etha-
nol, and embedded in epon resin. For ultrathin cryosectioning, MNT-1 
cells fixed with 2% PFA and 0.2% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.4) were processed for ultracryomicrotomy and immuno-
gold labeled using TYRP1 antibody (TA99) followed by protein A con-
jugated to 10 nm gold (PAG10). Electron micrographs were acquired 
using Philips CM120 or Tecnai Spirit G2 (FEI) equipped with a nu-
meric camera (Keen View; Soft Imaging System) or 4k charge coupled 
device camera (Quemesa; Olympus).
Immunoblotting
MNT-1 cells were seeded at 106 per 10-cm Petri dish and transfected 
with Oligofectamine (Invitrogen) 2 d later with control- or VAMP7-spe-
cific siRNAs and then again after an additional 3 d. 3 d later, cells were 
washed in cold PBS and incubated in cold lysis buffer (50 mM Tris, 
150 mM NaCl, 0.1% Triton X-100, and 10 mM EDTA, pH 7.2, supple-
mented with protease inhibitor cocktail [Roche]) for 20 min on ice. Cell 
lysates were collected by scraping and clarified by centrifugation for 15 
min at 13,000 rpm (4°C). Lysates were incubated with sample buffer 
(2× concentrated), boiled for 5 min, and processed for immunoblotting.
Quantification of melanin content
MNT-1 cells were seeded at 105 per well in a six-well plate and trans-
fected twice with siRNA as for immunoblotting. 3 d after the second 
siRNA transfection, cells were washed twice in cold PBS and incubated 
with 200 µl cold melanin buffer (50 mM Tris, 150 mM NaCl, and 2 mM 
EDTA, pH 7.2). Cells were scraped and sonicated, and 100 µl lysate was 
centrifuged at 13,000 rpm for 15 min at 4°C. Supernatants were removed 
and pellets washed with 500 µl ethanol/ether (1:1 ratio) and dissolved in 
230 µl 2 M NaOH/20% DMSO for 1 h at 60°C. The optical density at 
490 nm of 200 µl of solubilized melanin was measured and normalized to 
protein content evaluated by Bradford assay (Thermo Fisher Scientific).
FM
Standard immuno-FM and colocalization analyses. Cells were plated 
on Matrigel-coated coverslips, fixed with 3% PFA in Hank’s buff-
ered salt solution, labeled with primary and secondary antibodies and 
mounted using Vectashield H-1000 (Vector Laboratories). Cells were 
analyzed by epifluorescence microscopy on a DM IRBE or DMI 6000B 
microscope (Leica Biosystems) equipped with a 63× Plan Apochromat 
objective (1.4 NA) and either a Retiga EXi Fast 1394 or a Hamamatsu 
Photonics ORCA-Flash4.0 sCMOS digital camera. Images were ac-
quired in z-stacks using a 0.2-µm (DM IRBE) or 0.19-µm (DMI 6000B) 
step size and deconvolved using either subtractive volume deconvolu-
tion with OpenLab (PerkinElmer) software or Gold’s Method decon-
volution with three iterations in LASX (Leica Biosystems) software.
Quantification of overlap between markers in melanosomes. 
Quantification of the area of overlap in the cell periphery between two 
fluorescent labels or a fluorescent label and pigmented melanosomes 
was performed using ImageJ (National Institutes of Health) on wide-
field fluorescence images using a method similar to that previously 
used with OpenLab software (Setty et al., 2007). In brief, images were 
cropped to contain a single cell with the nucleus and perinuclear area 
removed, and binary images of fluorescence were generated by sub-
tracting the local background before thresholding using parameters 
of a rolling ball radius of 10 pixels with smoothing disabled. Binary 
images of pigment granules from BF imaging were generated by man-
ual thresholding. The Image Calculator function was used to generate 
an image representing the area of overlap between channels by mul-
tiplying the binary images for each of the two channels. The areas of 
overlap and of total fluorescent labeling in structures larger than five 
pixels were quantified using the Analyze Particles function; the ratio of 
overlap pixels to total fluorescent pixels in the channel of interest gives 
the percentage of overlap.
Transient rescue of BLOC-1− cells expressing GFP-VAMP7, 
TYRP-GFP, and mCh-STX13. BLOC-1−/− melan-pa cells were seeded 
on Matrigel-coated coverslips in 24-well tissue culture plates and 
24  h later transiently transfected with Lipofectamine using 200 ng 
each of pEGFP-C-VAMP7 and pmCh-C1-STX13 and 500 ng of ei-
ther pBMN-IRES-Hygro-mycMu or pBMN-IRES-Hygro-mycPa. At 
indicated times after transfection, cells were fixed with 3% PFA in 
Hank’s buffered salt solution and either mounted directly using Vecta-
shield or processed for standard immuno-FM as described above with 
either TA99 or HMB-45 and Dylite647-conjugated secondary antibod-
ies. Cells were imaged as for standard immuno-FM. The number of 
GFP-VAMP7-positive, mCH-STX13-negative puncta was quantified 
by manual counting within selected 200 × 200–pixel regions in the pe-
riphery of cells. Quantification of overlap between GFP-VAMP7 and 
mCh-STX13 in the cell periphery was completed as described above 
for Standard immuno-FM and colocalization analyses.
Quantification of melanosomal and endosomal VARP localiza-
tion using site-directed VARP mutants. WT melan-Ink4a melanocytes 
were seeded on Matrigel-coated coverslips and transfected using Li-
pofectamine 2000 with mCh-STX13 and either pLXIN-VARP(WT)-
EGFP or the site-directed pLXIN-VARP-GFP mutants deficient for 
binding to VAMP7 only, RAB38 only, both VAMP7 and RAB38, or 
retromer. 48  h after transfection, cells were fixed and processed for 
standard immuno-FM and deconvolved using LASX and Gold’s 
method (three iterations). Quantification of VARP-GFP puncta asso-
ciated with melanosomes visualized by BF microscopy or associated 
with mCh-STX13–labeled endosomes was done by manual counting 
after excluding a 200-pixel-diameter circular selection containing the 
nucleus and Golgi region.
Live-cell imaging
Cells were seeded in Matrigel-coated 35-mm glass-bottom dishes and 
transiently transfected with indicated GFP- or mCh/mRFP-fusion pro-
teins using Lipofectamine 2000. At indicated times after transfection, 
 o
n
 August 18, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published August 1, 2016
VAmP7 into and out of melanosomes • Dennis et al. 305
cells in riboflavin-free RPMI (US Biological) containing 10% FBS were 
imaged on a Axiovert 200 microscope (ZEI SS) equipped with a 63X 
Plan-Apo objective lens (NA 1.4), an UltraVIEW ERS6 spinning-disk 
confocal scan head (PerkinElmer), an environmental chamber at 37°C, 
an Orca ER CCD camera (Hamamatsu Photonics) and Volocity (Perkin- 
Elmer) software for image acquisition. In some experiments, an 
ORCA-Flash4.0 sCMOS camera was used instead. For imaging of cells 
expressing GFP-VAMP7 relative to melanosomes imaged by BF micros-
copy (Fig. 5, a–c; and Fig. S2 i), we used an Olympus IX71 spinning-disk 
confocal microscope equipped with a 100× Plan-Apo objective (NA 
1.4), LCI Chamlide stagetop incubation chamber at 37°C/5% CO2, an 
ImageEM EM-CCD camera (Hamamatsu Photonics), and MetaMorph 
(Molecular Devices) software for image acquisition. Image sequences 
were further analyzed using ImageJ. All images were captured at ∼1 
frames per second (fps) except for Video 9, which was captured at ∼1.4 fps.
Quantification of GFP-VAMP7 and mCh-STX13 tubule length  
and stability
To quantify the length and stability of GFP-VAMP7 and mCh-STX13 
tubules in WT melan-Ink4a melanocytes, cells were seeded in Matrigel- 
coated 35 mm glass-bottom dishes, cotransfected with GFP-VAMP7 
and mCh-STX13 and imaged 24  h later as described in the section 
above at ∼1 fps. Tubule length was measured by tracing the tubule at 
its maximum length using the “Measure” command in ImageJ, and tu-
bule stability was measured by counting the total number of frames in 
which an identifiable tubule was present. 50 total tubules (five tubules 
from each of ten cells, acquired on at least three independent days) 
were quantified for each type of tubule.
Quantification of GFP-VAMP7 tubules leaving melanosomes
To quantify the number of GFP-VAMP7 tubules leaving melanosomes in 
WT, BLOC-3–deficient, and BLOC-3–rescued cells, cells were seeded 
on Matrigel-coated 35-mm glass-bottom plates, transfected with GFP-
VAMP7 using Lipofectamine 2000, and imaged 24 h after transfection. 
Image sequences were acquired for 5 min at ∼1 fps (300 images) as de-
scribed above in the Live-cell imaging section. Quantification was com-
pleted using ImageJ Fiji. First, the perinuclear region of each cell was 
excluded by placing a circular region of interest with diameter 200 pixels 
over the nucleus and adjacent Golgi region as visualized by an accumu-
lation of GFP-VAMP7 signal. 50 × 50–pixel regions were selected and 
cropped from the periphery of each cell, avoiding the nuclear ROI and 
edges of the cell. Local background was subtracted from these 50-pixel- 
square regions using the “Process -> Subtract Background” command 
in ImageJ with settings of rolling ball radius of 10 pixels, and a sliding 
parabola with all other boxes unchecked; the resulting “background sub-
tracted” file was further processed using the “Smooth” command to yield 
a “smoothed” file. The “Combine” command was then used to place the 
“background subtracted” and “smoothed” files adjacent to each other, 
and only fission of tubules that were observed in both files were included 
in the quantification. For quantification, the number of GFP-VAMP7 
tubules/vesicles observed to depart from GFP-VAMP7–labeled melano-
somes was manually counted over all 300 frames of an image sequence.
Statistical analysis
Statistical significance was determined by the unpaired two-tailed Stu-
dent’s t test. All values are indicated as ± SD. *, P < 0.05; **, P < 0.01; 
***, P < 0.005; and ****, P < 0.0001.
Online supplemental material
Fig. S1 provides supporting evidence that VAMP7 resides in 
melanosomes and that it is trapped in early endosomes in a second 
BLOC-1–deficient model. Fig. S2 shows a still image of the entire 
cell from a frame of an image sequence of GFP-VAMP7 or TYRP1-
GFP and mCh-STX13 in WT cells, an inset of which is shown in Fig. 4 
and Videos 1 and 2; a corresponding image sequence of GFP-VAMP7 
and mCh-STX13 in BLOC-1–deficient cells as a control, also seen in 
Video 5; quantification of GFP-VAMP7 and mCh-STX13 tubule length 
and stability in WT melan-Ink4a melanocytes; still images of the entire 
cell from the first frame of image sequences of insets shown in Fig. 5, 
and Videos 6 and 7; and an image sequence in which a GFP-VAMP7–
labeled tubule emerges from a melanosome labeled by mRFP-OCA2, 
supporting Fig. 5 and Video 8. Fig. S3 shows the entire cell from the 
first frame of image sequences, insets of which are shown in Fig. 6 and 
Videos 9 and 11, and shows image sequences derived from Video 10, 
in which a tubule marked by VARP-GFP, but not TYRP1-mRFP, 
exits a melanosome. Fig. S4 shows representative localization of the 
lysosomal protein LAMP2 and the melanosomal protein TYRP1 in WT 
and BLOC-3–deficient le :HPS1 and images from HPS4-deficient le 
melanocytes mock-rescued by expression of the BLOC-3 subunit HPS1 
(le :HPS1) in which neither RAB38-GFP nor VARP-GFP localization is 
restored to melanosomes, supporting Fig. 9. Fig. S5 provides supporting 
evidence that VARP and RAB38, but not VAMP7, are mislocalized and 
depleted from melanosomes in a second BLOC-3-deficient cell model. 
Video 1 shows that GFP-VAMP7 and mCh-STX13 label separate tubule 
populations in WT melanocytes. Video  2 shows that TYRP1-GFP is 
undetectable in anterograde mCh-STX13 tubules in WT melanocytes. 
Video  3 shows that GFP-VAMP7 is detected in mCh-STX13 tubules 
in transiently rescued melan-pa melanocytes with restored BLOC-1 
function. Video 4 shows that TYRP1-GFP is detected in mCh-STX13 
tubules in transiently rescued melan-pa melanocytes with restored 
BLOC-1 function. Video 5 shows that GFP-VAMP7 and mCh-STX13 
are retained in enlarged endosomes and that mCh-STX13 tubules are 
dramatically reduced in in BLOC-1–deficient melanocytes. Video  6 
shows that GFP-VAMP7–labeled tubules exit pigmented melanosomes. 
Video  7 shows that TYRP1-mRFP is undetectable in GFP-VAMP7–
labeled tubules that emerge from melanosomes labeled by GFP-VAMP7 
and TYRP1-mRFP. Video 8 shows that mRFP-OCA2 is undetectable in 
GFP-VAMP7-labeled tubules that emerge from melanosomes labeled 
by GFP-VAMP7 and mRFP-OCA2. Video 9 shows that mCh-VAMP7 
tubules are also labeled by VARP-GFP. Video 10 shows that TYRP1-
mRFP is undetectable in VARP-GFP–labeled tubules that emerge from 
TYRP1-mRFP–labeled melanosomes. Video  11 shows that mRFP-
OCA2 is undetectable in VARP-GFP–labeled tubules that emerge from 
mRFP-OCA2–labeled melanosomes. Video 12 shows that VARP-GFP 
labels tubules that originate from STX13-labeled endosomes but that 
these tubules are distinct from those that are labeled by mCh-STX13 and 
destined for melanosomes. Video 13 shows that GFP-RAB38 is present 
on mCh-VAMP7–containing tubules that emerge from melanosomes. 
Video  14 shows examples of regions of interest for quantification 
of GFP-VAMP7 tubules departing melanosomes in WT, le :HPS1, 
and le :HPS4 melanocytes for analyses shown in Fig.  10  d.  Online 
supplemental material is available at http ://www .jcb .org /cgi /content 
 /full /jcb .201605090 /DC1.
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